Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes

KMT2A partial tandem duplication (KMT2A-PTD) is an adverse risk factor in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), a potential therapeutic target, and an attractive marker of measurable residual disease. High initial KMT2A-PTD RNA levels have been linked to poor prognosis, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Harrison K., Gibson, Christopher J., Murdock, H. Moses, Davineni, Phani, Harris, Marian H., Wang, Eunice S., Gondek, Lukasz P., Kim, Annette S., Nardi, Valentina, Lindsley, R. Coleman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Stimulus Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327559/
https://www.ncbi.nlm.nih.gov/pubmed/35584376
http://dx.doi.org/10.1182/bloodadvances.2022007613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327559/
https://www.ncbi.nlm.nih.gov/pubmed/35584376
http://dx.doi.org/10.1182/bloodadvances.2022007613

Ejemplares similares